Gallamine: Difference between revisions
No edit summary |
m (Protected "Gallamine": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
(No difference)
|
Latest revision as of 16:24, 20 August 2015
Clinical data | |
---|---|
Trade names | Flaxedil |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C30H60N3O3+3 · 3 I− (gallamine triethiodide) C24H45N3O3 (gallamine) |
Molar mass | 891.529 g/mol (gallamine triethiodide) 423.633 g/mol (gallamine) |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Gallamine |
Articles |
---|
Most recent articles on Gallamine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Gallamine at Clinical Trials.gov Clinical Trials on Gallamine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Gallamine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Gallamine Discussion groups on Gallamine Directions to Hospitals Treating Gallamine Risk calculators and risk factors for Gallamine
|
Healthcare Provider Resources |
Causes & Risk Factors for Gallamine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Gallamine triethiodide (Flaxedil) is a non-depolarising muscle relaxant.[1] It acts by combining with the cholinergic receptor sites in muscle and competitively blocking the transmitter action of acetylcholine.[2] Gallamine triethiodide has a parasympatholytic effect on the cardiac vagus nerve which causes tachycardia[3][4] and occasionally hypertension. Very high doses cause histamine release.
Gallamine triethiodide is commonly used to stabilize muscle contractions during surgical procedures.
It was developed by Daniel Bovet in 1947.[5]
The pharmaceutical is no longer marketed in the United States, according to the FDA Orange Book.
References
- ↑ "Webster's Online Dictionary - Flaxedil". Retrieved 2008-12-15.
- ↑ "RxMed: Pharmaceutical Information - FLAXEDIL". Retrieved 2008-12-15.
- ↑ Morgenstern C, Splith G (October 1965). "[Studies on the causes of gallamine tachycardia and its antagonistic modification by beta adrenolytics]". Der Anaesthesist (in German). 14 (10): 298–301. PMID 4380161.
|access-date=
requires|url=
(help) - ↑ WALTS LF (1963). "Ventricular tachycardia with gallamine and cyclopropane anesthesia". Anesthesiology. 24: 119. doi:10.1097/00000542-196301000-00024. PMID 13998750. Retrieved 2014-09-20.
- ↑ Raghavendra T (July 2002). "Neuromuscular blocking drugs: discovery and development". J R Soc Med. 95 (7): 363–7. doi:10.1258/jrsm.95.7.363. PMC 1279945. PMID 12091515.
- Pages with script errors
- Pages using citations with accessdate and no URL
- CS1 maint: Unrecognized language
- Template:drugs.com link with non-standard subpage
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Muscle relaxants
- Quaternary ammonium compounds
- Phenol ethers
- Drug